Agenus Inc. [NASDAQ: AGEN] price plunged by -7.05 percent to reach at -$0.16. The company report on April 8, 2022 that Agenus Presents Data on AGEN1571 (anti-ILT2) at AACR and Announces IND Clearance.
First data presentation on AGEN1571 shows strong adaptive and innate immune responses.
Preclinical data indicate superior performance to the only clinical-stage competitor.
A sum of 3973395 shares traded at recent session while its average daily volume was at 4.26M shares. Agenus Inc. shares reached a high of $2.295 and dropped to a low of $2.11 until finishing in the latest session at $2.11.
The one-year AGEN stock forecast points to a potential upside of 78.18. The average equity rating for AGEN stock is currently 1.70, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Agenus Inc. [AGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGEN shares is $9.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGEN stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Agenus Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 16, 2021. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on November 19, 2019, representing the official price target for Agenus Inc. stock. On October 28, 2016, analysts decreased their price target for AGEN shares from 10 to 5.
The Average True Range (ATR) for Agenus Inc. is set at 0.14, with the Price to Sales ratio for AGEN stock in the period of the last 12 months amounting to 1.91. The Price to Book ratio for the last quarter was 16.23, with the Price to Cash per share for the same quarter was set at 1.14.
AGEN Stock Performance Analysis:
Agenus Inc. [AGEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.52. With this latest performance, AGEN shares dropped by -24.37% in over the last four-week period, additionally sinking by -57.80% over the last 6 months – not to mention a drop of -27.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGEN stock in for the last two-week period is set at 33.09, with the RSI for the last a single of trading hit 27.37, and the three-weeks RSI is set at 36.74 for Agenus Inc. [AGEN]. The present Moving Average for the last 50 days of trading for this stock 2.63, while it was recorded at 2.26 for the last single week of trading, and 4.04 for the last 200 days.
Insight into Agenus Inc. Fundamentals:
Agenus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.10.
Agenus Inc. [AGEN] Insider Position Details
There are presently around $304 million, or 58.90% of AGEN stock, in the hands of institutional investors. The top three institutional holders of AGEN stocks are: STATE STREET CORP with ownership of 21,170,850, which is approximately 71.939% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 17,649,673 shares of the stock with an approximate value of $40.06 million in AGEN stocks shares; and VANGUARD GROUP INC, currently with $40.03 million in AGEN stock with ownership of nearly 18.072% of the company’s market capitalization.
113 institutional holders increased their position in Agenus Inc. [NASDAQ:AGEN] by around 30,292,133 shares. Additionally, 65 investors decreased positions by around 16,868,600 shares, while 31 investors held positions by with 86,825,277 shares. The mentioned changes placed institutional holdings at 133,986,010 shares, according to the latest SEC report filing. AGEN stock had 40 new institutional investments in for a total of 4,438,352 shares, while 33 institutional investors sold positions of 7,837,247 shares during the same period.